The novel Bruton's tyrosine kinase inhibitor ARQ531 disrupts survival signaling and triggers apoptosis in AML cells

被引:0
|
作者
Debora, Soncini [1 ]
Orecchioni, Stefania [2 ]
Cagnetta, Antonia [1 ]
Retali, Veronica [1 ]
Ruberti, Samantha [1 ]
Minetto, Paola [1 ]
Contini, Paola [1 ]
Nencioni, Alessio [1 ]
Monacelli, Fiammetta [1 ]
Hall, Terence [3 ]
Gobbi, Marco [1 ]
Eathiraj, Sudharshan [3 ]
Schwartz, Briam [3 ]
Bertolini, Francesco [2 ]
Lemoli, Roberto [1 ]
Cea, Michele [1 ]
机构
[1] Univ Genoa, Genoa, Italy
[2] European Inst Oncol, Milan, Italy
[3] ARQULE, Burlington, MA USA
关键词
D O I
10.1158/1538-7445.AM2018-793
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
793
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
    Bruns, CJ
    Solorzano, CC
    Harbison, MT
    Ozawa, S
    Tsan, R
    Fan, D
    Abbruzzese, J
    Traxler, P
    Buchdunger, E
    Radinsky, R
    Fidler, IJ
    CANCER RESEARCH, 2000, 60 (11) : 2926 - 2935
  • [42] Evaluation of TL-895, a novel Bruton's Tyrosine Kinase inhibitor (BTKi), on oncogenic Janus Kinase 2-V617F (JAK2VF) signaling
    Nimmagadda, S. C.
    Budde, P. M.
    Sun, K.
    Patnana, P. K.
    Ahmed, H. M. M.
    Covey, T.
    Krejsa, C. M.
    Rothbaum, W. P.
    von Bubnoff, N. C. C.
    Khandanpour, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 220 - 220
  • [43] Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
    Sinha, Meenal
    Betts, Courtney
    Zhang, Li
    Griffith, Madeline J.
    Solman, Isabelle
    Chen, Brandon
    Liu, Eric
    Tamaki, Whitney
    Stultz, Jacob
    Marquez, Jaqueline
    Sivagnanam, Shamilene
    Cheung, Alexander
    Pener, Denise
    Fahlman, Anne
    Taber, Erin
    Lerner, Kimberly
    Crocker, Matthew
    Todd, Kendra
    Rajagopalan, Brindha
    Ware, Clarisha
    Bridge, Mark
    Vo, Johnson
    Dragomanovich, Hannah
    Sudduth-Klinger, Julie
    Vaccaro, Gina
    Lopez, Charles D.
    Tempero, Margaret
    Coussens, Lisa M.
    Fong, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
  • [44] Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
    Sinha, Meenal
    Betts, Courtney
    Zhang, Li
    Griffith, Madeline J.
    Solman, Isabelle
    Chen, Brandon
    Liu, Eric
    Tamaki, Whitney
    Stultz, Jacob
    Marquez, Jaqueline
    Sivagnanam, Shamilene
    Cheung, Alexander
    Pener, Denise
    Fahlman, Anne
    Taber, Erin
    Lerner, Kimberly
    Crocker, Matthew
    Todd, Kendra
    Rajagopalan, Brindha
    Ware, Clarisha
    Bridge, Mark
    Vo, Johnson
    Dragomanovich, Hannah
    Sudduth-Klinger, Julie
    Vaccaro, Gina
    Lopez, Charles D.
    Tempero, Margaret
    Coussens, Lisa M.
    Fong, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
  • [45] Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells
    Liu, ZY
    Ganju, RK
    Wang, GF
    Ona, MA
    Hatch, WC
    Zheng, T
    Avraham, S
    Gill, P
    Groopman, JE
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07): : 1798 - 1804
  • [46] Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells
    Wang, Jingming
    Lau, Kai-Yeung
    Jung, Jimmy
    Ravindran, Palanikumar
    Barrat, Franck J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (04) : 1130 - 1136
  • [47] Bruton's Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia
    de Porto, Alexander P.
    Liu, Zhe
    de Beer, Regina
    Florquin, Sandrine
    Roelofs, Joris J. T. H.
    de Boer, Onno J.
    den Haan, Joke M. M.
    Hendriks, Rudi W.
    van 't Veer, Cornelis
    van der Poll, Tom
    de Vos, Alex F.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis
    Francesco Albano
    Federico Chiurazzi
    Selena Mimmi
    Eleonora Vecchio
    Arianna Pastore
    Clementina Cimmino
    Camilla Frieri
    Enrico Iaccino
    Antonio Pisano
    Gaetanina Golino
    Giuseppe Fiume
    Massimo Mallardo
    Giuseppe Scala
    Ileana Quinto
    Cell Death & Disease, 9
  • [49] The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis
    Albano, Francesco
    Chiurazzi, Federico
    Mimmi, Selena
    Vecchio, Eleonora
    Pastore, Arianna
    Cimmino, Clementina
    Frieri, Camilla
    Iaccino, Enrico
    Pisano, Antonio
    Golino, Gaetanina
    Fiume, Giuseppe
    Mallardo, Massimo
    Scala, Giuseppe
    Quinto, Ileana
    CELL DEATH & DISEASE, 2018, 9
  • [50] TAS5315, a Novel Bruton's Tyrosine Kinase Inhibitor, Ameliorates Inflammation and Bone Erosion in Murine Model for Rheumatoid Arthritis
    Yoshiga, Yohei
    Hosoi, Fumihito
    Iguchi, Satoru
    Kaneko, Ryuusuke
    Nakachi, Yoshinori
    Akasaka, Daichi
    Tanaka, Kenji
    Yonekura, Kazuhiko
    Utsugi, Teruhiro
    Sasaki, Eiji
    Iwasawa, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2017, 69